Sensitivity Comparison of Pleural Fluid and Serum Neutrophil to Lymphocyte Ratio (NLR) Values in Exudative Pleural Effusion Patients

Indra Barata, Zainuddin Amir, Parluhutan Siagian, Putri C Eyanoer, Zulfikar Lubis

Abstract


Background: Delay in diagnosis and non-compliance to tuberculosis (TB) treatment will increase the risk of MDR TB. WHO recommends GeneXpert as a diagnostic tool, however, the availability is still an obstacle and this tool is not owned by many health facilities. The Neutrophil-Lymphocyte Ratio (NLR) value was thought to be used to estimate the likelihood of TB cases. This study aimed to assess the sensitivity comparison of pleural fluid and serum NLR values in patients with pleural effusion at H. Adam Malik Medan General Hospital.
Methods: This was an analytical study with a diagnostic test design, by calculating the sensitivity and specificity of pleural fluid and serum NLR. The sample was calculated by comparing the absolute neutrophil count and the absolute lymphocyte count from both pleural fluid and serum.
Results: The sample of this study was 78 patients. In this study, pleural fluid NLR with a cut off value of 2.2 showed a sensitivity of 74% and specificity of 28%, whereas serum NLR with a cut off value of 7.0 produced a sensitivity of 53% and specificity of 68%.
Conclusion: The sensitivity of pleural fluid NLR was greater than that of serum, while the specificity of serum NLR was more superior than that of pleural fluid.

Keywords


Neutrophil-Lymphocyte Ratio; Tuberculosis; Pleural NLR; Serum NLR

References


World Health Organization. Course on MDR-TB. France: The World Medical Association; 2013.p.1-220.

Kementerian Kesehatan Republik Indonesia. Pengobatan Pasien TB Resistant Obat. Jakarta: Kemenkes RI; 2016.p.78-113.

Akturk UA, Ernam D, Akbay MO, Koc ak ND, Ogur E, Irmak I. Role of The Neutrophil-lymphocyte Ratio in the Differential Diagnosis of exudative Pleural Effusion. Turkey: Clinics; 2016.71(10):611-6.

Hasibuan P & Soeroso NN. Buku Ajar Respirologi FK USU: Kanker Paru. Medan: USU Press; 2017.p.398-401.

Colquhoun D, Cray M, Ikram R, Jensen P, Kyle C, Leathart C, McBain L, Reid J, Reith D, Tilyard M. Complete Blood Count in Primary Care. 7th ed. Dunedin, NZ: Best Practice Advocacy Centre; 2008. p.1-20.

Mileshkin LR, Freimund AE. Improvement of Outcomes for Women With HIV Infection and Cervical Cancer. J Clin Oncol. 2016; 34(31):3749.

Purba T. Analisis Hubungan Antara Tingkat Pendidikan Dan Kontak Serumah Dengan Kejadian Tuberkulosis Paru Di Wilayah Kerja Puskesmas Ranotana Weru Kota Manado [thesis]. Manado: Universitas Sam Ratulangi.; 2016.

Hasan H. Buku Ajar Ilmu Penyakit Paru: Tuberkulosis Paru. Surabaya: Pusat Penerbitan Departemen Ilmu Penyakit Paru Fakultas Kedokteran Universitas Airlangga; 2010.

Antin SS, KashinkuntiM, Darshana R, Dhananjaya M. Use of pleural fluid lymphocyte neutrophil ratio in addition to pleural fluid adenosine deaminase for the diagnosis of tuberculous pleural effusion. Sch J App Med Sci: 2014. 2(2A):498-501.

Hidayat Kusnadi. Hubungan Jenis Leukosit dengan Kejadian Tuberkulosis di Balai Kesehatan Paru Masyarakat Makassar. Jakarta: Jurnal Tuberkulosis Indonesia; 2010;3(2):6-15.

Karthik K, Manickam K, Paramasivam T, Mani S, Dashprakash M. Neutrophils in tuberculosis: Will code be unlocked?. Vet World 2013 [cited 2012 Dec 01]: 6(2): 118-121. Available from: www.veterinaryworld.org.

Li J et all. Neutrophil-to-Lymphocyte Ratio Positively Correlates to Age in Healthy Population. China: Journal of Clinical Laboratory Analysis; 2015.29(6):437-43.

Salim DK, Mutlu H, Eryilmaz MK, Salim O, Musri FY, Tural D, et al. The Neutrophil/Lymphocyte Ratio may be an indicator of advanced disease in patients with non-small cell lung cancer. Adv Lab Med Int. 2012. p.142-8.

Perhimpunan Dokter Paru Indonesia. Pedoman Diagnosis dan Penatalaksanaan Tuberkulosis di Indonesia. Jakarta: PDPI; 2011. p. 1-21.

Elizabeth MS Tobing, Widirahardjo. Characteristic of Patiens With Pleurall Effusion in RSUP H. Adam Malik Medan. Medan: E- Jurnal FK USU; 2013:10-13.

Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, et al. Prognostic value of platelet count and lymphocite to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion. PLoS ONE. 2018:1-13.

Lee YS, Nam HS, Lim JH, Kim JS, Moon YS, Cho JH, et al. Prognostic impact of new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patient. BMC Cancer. 2017:1-8.

Yan Gu, Khan Zhai, Huan-Zhong Shi. Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion. Chin Med J. 2016:1-6.

Verma A, Dagaonkar RS, Marshall D, Abisheganaden JM, Light RW. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lyphocyte Count). Can Respir J. 2016:1-6.

Nikolić I, Kukulj S, Samaržija M, Jeleč V, Žarak M, Orehovec, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes. CMJ. 2016:287-92.

Lee H, Um SJ, Kim YS, Kim DK, Jang AS, Choi HS, et al. Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016:1-12.

Zhang H, Zhang L, Zhu K, Shi B, Yin Y, Zhu J, et al. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study. PLoS ONE. 2016:1-16.

Ozyurek et all. Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases. Asian Pac J Cancer Prev. 2017:1417-21.

Light RW. Tuberculous pleural effusion. In: Light RW, ed. Pleural Diseases. 6th ed. New York, NY: Lippincott Williams & Wilkins; 2013. p.247-62.




DOI: https://doi.org/10.36497/jri.v40i4.131

Refbacks

  • There are currently no refbacks.




Copyright (c) 2020 Indra Barata, Zainuddin Amir, Parluhutan Siagian, Putri C Eyanoer, Zulfikar Lubis


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter